Michelle J. Cox

1.2k total citations
24 papers, 144 citations indexed

About

Michelle J. Cox is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Michelle J. Cox has authored 24 papers receiving a total of 144 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Michelle J. Cox's work include CAR-T cell therapy research (22 papers), Virus-based gene therapy research (4 papers) and CRISPR and Genetic Engineering (4 papers). Michelle J. Cox is often cited by papers focused on CAR-T cell therapy research (22 papers), Virus-based gene therapy research (4 papers) and CRISPR and Genetic Engineering (4 papers). Michelle J. Cox collaborates with scholars based in United States, Germany and China. Michelle J. Cox's co-authors include Saad S. Kenderian, Reona Sakemura, Rosalie M. Sterner, Mehrdad Hefazi, Elizabeth L. Siegler, Kendall J. Schick, Claudia Manriquez Roman, Michael W. Ruff, İsmail Can and Erin E. Tapper and has published in prestigious journals such as Blood, Cancer Research and Landscape Ecology.

In The Last Decade

Michelle J. Cox

23 papers receiving 144 citations

Peers

Countries citing papers authored by Michelle J. Cox

Since Specialization

Citations

This map shows the geographic impact of Michelle J. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle J. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle J. Cox more than expected).

Fields of papers citing papers by Michelle J. Cox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle J. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle J. Cox. The network helps show where Michelle J. Cox may publish in the future.

Co-authorship network of co-authors of Michelle J. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle J. Cox. A scholar is included among the top collaborators of Michelle J. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle J. Cox. Michelle J. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 1153: IL-4 depletion leads to the improvement of CART cell therapy 2023 ·Cancer Research ·(unknown), Michelle J. Cox, Reona Sakemura, (unknown), İsmail Can, Claudia Manriquez Roman, (unknown), Olivia Sirpilla, (unknown), (unknown), Elizabeth L. Siegler, Jaeyeon Kim, (unknown), Nathalie Scholler, (unknown), Saad S. Kenderian	1
2	The invasive plant data landscape: a synthesis of spatial data and applications for research and management in the United States 2023 ·Landscape Ecology ·Emily J. Fusco, Evelyn M. Beaury, Bethany A. Bradley, Michelle J. Cox, Catherine S. Jarnevich, Adam L. Mahood, R. Chelsea Nagy, (unknown), Jessica E. Halofsky	4
3	Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography 2022 ·Journal of Visualized Experiments ·Reona Sakemura, Michelle J. Cox, Aditya Bansal, Claudia Manriquez Roman, Mehrdad Hefazi, (unknown), (unknown), Mukesh K. Pandey, Timothy R. DeGrado, Elizabeth L. Siegler, Saad S. Kenderian	5
4	Challenges of chimeric antigen receptor T-cell therapy in chronic lymphocytic leukemia: lessons learned 2022 ·Experimental Hematology ·İsmail Can, Michelle J. Cox, Elizabeth L. Siegler, Reona Sakemura, Saad S. Kenderian	11
5	Chimeric Antigen Receptor Engineering of Mesenchymal Stromal Cells (CAR-MSC) Enhance Immunosuppression and Outcomes in Graft Versus Host Disease (GvHD) Preclinical Models 2022 ·Blood ·Olivia Sirpilla, Reona Sakemura, Mehrdad Hefazi, (unknown), (unknown), Michelle J. Cox, Kendall J. Schick, (unknown), İsmail Can, (unknown), (unknown), (unknown), Elizabeth L. Siegler, Saad S. Kenderian	5
6	Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography 2022 ·Journal of Visualized Experiments ·Reona Sakemura, Michelle J. Cox, (unknown), Claudia Manriquez Roman, Mehrdad Hefazi, (unknown), (unknown), Mukesh Kumar Pandey, Timothy R. DeGrado, Elizabeth L. Siegler, Saad S. Kenderian	1
7	Identification of IL-4 As a Key Regulator of CAR T-Cell Exhaustion Using Functional Genomics and Correlates of the Zuma-1 Clinical Trial 2022 ·Blood ·(unknown), Michelle J. Cox, Reona Sakemura, (unknown), İsmail Can, (unknown), (unknown), Olivia Sirpilla, (unknown), (unknown), Elizabeth L. Siegler, Jaeyeon Kim, (unknown), Nathalie Scholler, (unknown), Saad S. Kenderian	7
8	Omics analyses provide insights to CART cell therapy resistance 2021 ·Michelle J. Cox, Saad S. Kenderian	0
9	Resistance to CART cell therapy: lessons learned from the treatment of hematological malignancies 2021 ·Leukemia & lymphoma ·Reona Sakemura, Michelle J. Cox, Mehrdad Hefazi, Elizabeth L. Siegler, Saad S. Kenderian	12
10	Targeting Cancer Associated Fibroblasts in the Bone Marrow Prevents Resistance to Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma 2020 ·Biology of Blood and Marrow Transplantation ·Reona Sakemura, Michelle J. Cox, Mehrdad Hefazi, Michael J. Hansen, Roman H. Khadka, Claudia Manriquez Roman, Kendall J. Schick, Erin E. Tapper, Paulina Horvei, Michael W. Ruff, Denise K. Walters, Sameer A. Parikh, Neil E. Kay, Saad S. Kenderian	1
11	Targeting of CD19 By Tafasitamab Does Not Impair CD19 Directed Chimeric Antigen Receptor T Cell Activity in Vitro 2020 ·Biology of Blood and Marrow Transplantation ·Paulina Horvei, Reona Sakemura, Michelle J. Cox, Claudia Manriquez Roman, Kendall J. Schick, Michael W. Ruff, Mehrdad Hefazi, Erin E. Tapper, Michael J. Hansen, Jürgen Schanzer, Jan Endell, Neil E. Kay, Grzegorz S. Nowakowski, Saad S. Kenderian	7
12	Circulating Extracellular Vesicles Induce Chimeric Antigen Receptor T Cell Dysfunction in Chronic Lymphocytic Leukemia (CLL) 2020 ·Biology of Blood and Marrow Transplantation ·Michelle J. Cox, (unknown), Reona Sakemura, Justin C. Boysen, Yohan Kim, Michael J. Hansen, Claudia Manriquez Roman, Erin E. Tapper, (unknown), Kendall J. Schick, Mehrdad Hefazi, Paulina Horvei, Michael W. Ruff, Sameer A. Parikh, Neil E. Kay, Saad S. Kenderian	3
13	Improved Anti-Tumor Response of Chimeric Antigen Receptor T Cell (CART) Therapy after GM-CSF Inhibition Is Mechanistically Supported By a Novel Direct Interaction of GM-CSF with Activated Carts 2019 ·Blood ·Michelle J. Cox, (unknown), Rosalie M. Sterner, Reona Sakemura, Sutapa Sinha, Raphael Mwangi, (unknown), Mehrdad Hefazi, Omar Abdihamid, Dale Chappell, Cameron Durrant, Claudia Manriquez Roman, Kendall J. Schick, Erin E. Tapper, Paulina Horvei, Michael W. Ruff, Sameer A. Parikh, Neil E. Kay, Saad S. Kenderian	3
14	Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells 2019 ·Journal of Visualized Experiments ·Rosalie M. Sterner, Michelle J. Cox, Reona Sakemura, Saad S. Kenderian	30
15	Targeting of CD19 By Tafasitamab Does Not Impair CD19 Directed Chimeric Antigen Receptor T Cell Activity in Vitro 2019 ·Blood ·Paulina Horvei, Reona Sakemura, Michelle J. Cox, Michael W. Ruff, Mehrdad Hefazi, Erin E. Tapper, Kendall J. Schick, Claudia Manriquez Roman, (unknown), (unknown), Jan Endell, Grzegorz S. Nowakowski, Neil E. Kay, Saad S. Kenderian	9
16	Axl-RTK Inhibition Modulates T Cell Functions and Synergizes with Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies 2019 ·Biology of Blood and Marrow Transplantation ·Reona Sakemura, Nan Yang, Michelle J. Cox, Sutapa Sinha, Mehrdad Hefazi, Michael J. Hansen, Kendall J. Schick, Justin C. Boysen, Renee C. Tschumper, (unknown), Jason M. Foulks, Steven L. Warner, Sameer A. Parikh, Wei Ding, Neil E. Kay, Saad S. Kenderian	2
17	Targeting Cancer Associated Fibroblasts in the Bone Marrow Prevents Resistance to Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma 2019 ·Blood ·Reona Sakemura, Michelle J. Cox, Michael J. Hansen, Mehrdad Hefazi, Claudia Manriquez Roman, Kendall J. Schick, Erin E. Tapper, (unknown), Michael W. Ruff, Denise K. Walters, Sameer A. Parikh, Neil E. Kay, Saad S. Kenderian	15
18	Circulating Extracellular Vesicles Induce Chimeric Antigen Receptor T Cell Dysfunction in Chronic Lymphocytic Leukemia (CLL) 2019 ·Blood ·Michelle J. Cox, (unknown), Reona Sakemura, Justin C. Boysen, Yohan Kim, Michael J. Hansen, Claudia Manriquez Roman, Erin E. Tapper, (unknown), Kendall J. Schick, Mehrdad Hefazi, (unknown), Michael W. Ruff, Sameer A. Parikh, Neil E. Kay, Saad S. Kenderian	2
19	EXTH-32. DEVELOPMENT OF EPHA3 DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME 2019 ·Neuro-Oncology ·Michael W. Ruff, Reona Sakemura, Michelle J. Cox, (unknown), (unknown), Kendall J. Schick, Jann N. Sarkaria, Saad S. Kenderian	2
20	Axl-RTK Inhibition Modulates T Cell Functions and Synergizes with Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies 2018 ·Blood ·Reona Sakemura, Nan Yang, Michelle J. Cox, Sutapa Sinha, Mehrdad Hefazi, Michael J. Hansen, Kendall J. Schick, Cynthia L. Forsman, Justin C. Boysen, Renee C. Tschumper, (unknown), (unknown), Jason M. Foulks, Steven L. Warner, Sameer A. Parikh, Wei Ding, Neil E. Kay, Saad S. Kenderian	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact